The Scottish Medicine Consortium (SMC) has approved a drug called niraparib, providing new hope for women with recurrent ovarian cancer. Continue reading Scottish Medicine Consortium approves ‘new class’ of ovarian cancer drug
The Scottish Medicine Consortium (SMC) has approved a drug called niraparib, providing new hope for women with recurrent ovarian cancer. Continue reading Scottish Medicine Consortium approves ‘new class’ of ovarian cancer drug